or Try an Advanced Search...
    Invalid date chosen. Displaying data for the latest date instead.

    Technical Analysis for CLSD - Clearside Biomedical, Inc.

    Grade Last Price % Change Price Change
    D 1.34 2.29% 0.03
    CLSD closed unchanged on Friday, May 17, 2024, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical CLSD trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.29%
    20 DMA Support Bullish 2.29%
    Bollinger Band Squeeze Range Contraction 2.29%
    NR7 Range Contraction 2.29%
    Narrow Range Bar Range Contraction 2.29%
    Inside Day Range Contraction 2.29%
    20 DMA Support Bullish 2.29%
    Bollinger Band Squeeze Range Contraction 2.29%
    Doji - Bearish? Reversal 2.29%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.52%
    Older End-of-Day Signals for CLSD ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 2 hours ago
    Up 3% about 2 hours ago
    Up 2% about 2 hours ago
    Up 1% about 2 hours ago
    Possible NR7 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CLSD Chart by TradingView
    Basic chart:

    Profile

    Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Wet Age Related Macular Degeneration Drug Therapies Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion

    Is CLSD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
    May 10 Q1 2024 Clearside Biomedical Inc Earnings Call
    May 10 Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript
    May 10 Clearside Biomedical, Inc. (CLSD) Q1 2024 Earnings Call Transcript
    May 9 Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
    May 9 Clearside Biomedical GAAP EPS of -$0.17 misses by $0.03, revenue of $0.23M misses by $0.45M
    May 9 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
    May 8 Clearside Biomedical Q1 2024 Earnings Preview
    May 8 Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
    Apr 30 Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024
    See more CLSD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.12
    52 Week Low 0.6501
    Average Volume 345,962
    200-Day Moving Average 1.16
    50-Day Moving Average 1.42
    20-Day Moving Average 1.30
    10-Day Moving Average 1.29
    Average True Range 0.10
    RSI (14) 49.24
    ADX 14.52
    +DI 15.02
    -DI 11.28
    Chandelier Exit (Long, 3 ATRs) 1.17
    Chandelier Exit (Short, 3 ATRs) 1.52
    Upper Bollinger Bands 1.39
    Lower Bollinger Band 1.22
    Percent B (%b) 0.54
    BandWidth 13.28
    MACD Line -0.02
    MACD Signal Line -0.03
    MACD Histogram 0.0094
    Fundamentals Value
    Market Cap 83.33 Million
    Num Shares 63.6 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -2.15
    Price-to-Sales 40.85
    Price-to-Book 3.93
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.37
    Resistance 3 (R3) 1.37 1.36 1.36
    Resistance 2 (R2) 1.36 1.34 1.36 1.36
    Resistance 1 (R1) 1.33 1.33 1.35 1.33 1.35
    Pivot Point 1.32 1.32 1.32 1.32 1.32
    Support 1 (S1) 1.29 1.30 1.31 1.29 1.27
    Support 2 (S2) 1.28 1.29 1.28 1.26
    Support 3 (S3) 1.25 1.28 1.26
    Support 4 (S4) 1.25